124 related articles for article (PubMed ID: 8391833)
1. Salvage treatment after r-interferon alpha-2a in advanced neuroendocrine tumors.
Zilembo N; Buzzoni R; Bajetta E; Di Bartolomeo M; de Braud F; Castellani R; Maffioli L; Celio L; Villa E; Lorusso V
Acta Oncol; 1993; 32(2):245-50. PubMed ID: 8391833
[TBL] [Abstract][Full Text] [Related]
2. Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a. A study by the Italian Trials in Medical Oncology Group.
Bajetta E; Zilembo N; Di Bartolomeo M; Di Leo A; Pilotti S; Bochicchio AM; Castellani R; Buzzoni R; Celio L; Dogliotti L
Cancer; 1993 Nov; 72(10):3099-105. PubMed ID: 7693327
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group.
di Bartolomeo M; Bajetta E; Buzzoni R; Mariani L; Carnaghi C; Somma L; Zilembo N; di Leo A
Cancer; 1996 Jan; 77(2):402-8. PubMed ID: 8625251
[TBL] [Abstract][Full Text] [Related]
4. Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon alpha for advanced carcinoid tumors: FNCLCC-FFCD 9710.
Dahan L; Bonnetain F; Rougier P; Raoul JL; Gamelin E; Etienne PL; Cadiot G; Mitry E; Smith D; Cvitkovic F; Coudert B; Ricard F; Bedenne L; Seitz JF; ;
Endocr Relat Cancer; 2009 Dec; 16(4):1351-61. PubMed ID: 19726540
[TBL] [Abstract][Full Text] [Related]
5. A phase II trial of streptozotocin and adriamycin in advanced APUD tumors.
Frame J; Kelsen D; Kemeny N; Cheng E; Niedzwiecki D; Heelan R; Lippermann R
Am J Clin Oncol; 1988 Aug; 11(4):490-5. PubMed ID: 2841843
[TBL] [Abstract][Full Text] [Related]
6. Treatment with alpha-interferon versus alpha-interferon in combination with streptozocin and doxorubicin in patients with malignant carcinoid tumors: a randomized trial.
Janson ET; Rönnblom L; Ahlström H; Grandér D; Alm G; Einhorn S; Oberg K
Ann Oncol; 1992 Sep; 3(8):635-8. PubMed ID: 1450046
[TBL] [Abstract][Full Text] [Related]
7. Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.
Biesma B; Willemse PH; Mulder NH; Verschueren RC; Kema IP; de Bruijn HW; Postmus PE; Sleijfer DT; de Vries EG
Br J Cancer; 1992 Nov; 66(5):850-5. PubMed ID: 1384643
[TBL] [Abstract][Full Text] [Related]
8. A phase II trial of alpha-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumors.
Saltz L; Kemeny N; Schwartz G; Kelsen D
Cancer; 1994 Aug; 74(3):958-61. PubMed ID: 8039124
[TBL] [Abstract][Full Text] [Related]
9. Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma.
Von Moll L; McEwan AJ; Shapiro B; Sisson JC; Gross MD; Lloyd R; Beals E; Beierwaltes WH; Thompson NW
J Nucl Med; 1987 Jun; 28(6):979-88. PubMed ID: 3035114
[TBL] [Abstract][Full Text] [Related]
10. Nonsurgical treatment of advanced malignant neuroendocrine pancreatic tumors and midgut carcinoids.
Skogseid B
World J Surg; 2001 Jun; 25(6):700-3. PubMed ID: 11376401
[TBL] [Abstract][Full Text] [Related]
11. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
[TBL] [Abstract][Full Text] [Related]
12. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms.
Moertel CG; Kvols LK; O'Connell MJ; Rubin J
Cancer; 1991 Jul; 68(2):227-32. PubMed ID: 1712661
[TBL] [Abstract][Full Text] [Related]
13. Treatment of advanced neuroendocrine tumours using combination chemotherapy with lomustine and 5-fluorouracil.
Kaltsas GA; Mukherjee JJ; Isidori A; Kola B; Plowman PN; Monson JP; Grossman AB; Besser GM
Clin Endocrinol (Oxf); 2002 Aug; 57(2):169-83. PubMed ID: 12153595
[TBL] [Abstract][Full Text] [Related]
14. Combination of chemotherapy and recombinant alpha-interferon in advanced non-small cell lung cancer. Multicentric Randomized FONICAP Trial Report. The Italian Lung Cancer Task Force.
Ardizzoni A; Salvati F; Rosso R; Bruzzi P; Rubagotti A; Pennucci MC; Mariani GL; De Marinis F; Pallotta G; Antilli A
Cancer; 1993 Nov; 72(10):2929-35. PubMed ID: 8221559
[TBL] [Abstract][Full Text] [Related]
15. Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors.
Lastoria S; Maurea S; Vergara E; Acampa W; Varrella P; Klain M; Muto P; Bernardy JD; Salvatore M
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):145-9. PubMed ID: 9002775
[TBL] [Abstract][Full Text] [Related]
16. Endocrine tumors.
Averbuch SD
Cancer Chemother Biol Response Modif; 1991; 12():491-508. PubMed ID: 1681844
[No Abstract] [Full Text] [Related]
17. Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinoma.
Sznol M; Clark JW; Smith JW; Steis RG; Urba WJ; Rubinstein LV; VanderMolen LA; Janik J; Sharfman WH; Fenton RG
J Natl Cancer Inst; 1992 Jun; 84(12):929-37. PubMed ID: 1629914
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic possibilities of 131I-MIBG in metastatic carcinoid tumors--preliminary report.
Guerra P; Colombo L; Maira G; Pagliaini R; Terzi A; Pizzocaro C; Dottorini ME; Lomuscio G; Bestagno M
Tumori; 1990 Oct; 76(5):484-7. PubMed ID: 2256196
[TBL] [Abstract][Full Text] [Related]
19. 5-Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors.
Bajetta E; Rimassa L; Carnaghi C; Seregni E; Ferrari L; Di Bartolomeo M; Regalia E; Cassata A; Procopio G; Mariani L
Cancer; 1998 Jul; 83(2):372-8. PubMed ID: 9669822
[TBL] [Abstract][Full Text] [Related]
20. Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma.
Pazdur R; Ajani JJ; Abbruzzese JL; Belt RJ; Dakhil SR; Dubovsky D; Graham S; Pilat S; Winn R; Levin B
Cancer; 1992 Oct; 70(8):2073-6. PubMed ID: 1394037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
